Filing Details
- Accession Number:
- 0001104659-15-072542
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-23 21:45:39
- Reporting Period:
- 2015-10-21
- Filing Date:
- 2015-10-23
- Accepted Time:
- 2015-10-23 21:45:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1428522 | Radius Health Inc. | RDUS | Pharmaceutical Preparations (2834) | 800145732 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1501075 | Rob Ward | C/O Radius Health, Inc. 950 Winter St. Waltham MA 02145 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-10-21 | 50,000 | $7.80 | 50,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-10-21 | 50,000 | $61.99 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-10-21 | 29,811 | $0.00 | 29,811 | $7.80 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-10-21 | 20,189 | $0.00 | 20,189 | $7.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,820 | 2014-04-17 | 2024-02-15 | No | 4 | M | Direct |
| 768,785 | 2024-02-15 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2015.
- The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $60.00 to $66.34. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The exercise price and number of derivative securities was adjusted to reflect the stock split that occurred on April 24, 2014.
- This stock option vested as to 25% of the underlying shares upon consummation of the Issuer's initial public offering on June 6, 2014 and as to an additional 18.75% of the underlying shares on December 16, 2014. The remainder of the stock option vests in substantially equal installments on the 16th day of each of the 36 consecutive months beginning January 16, 2015.
Billionaire Hedge Funds
